Iraq says it has arrested top leader in Islamic State group

FAN Editor

Iraq says it has detained a top leader of the Islamic State group and a longtime al-Qaida operative in a cross-border operation

BAGHDAD — Iraq said on Monday it has detained a top leader of the Islamic State group and a longtime al-Qaida operative in a cross-border operation.

Iraqi Prime Minister Mustafa al-Kadhimi tweeted the news, identifying the man as Sami Jasim, who oversees the Islamic State group’s financial operations and served as the deputy leader of IS under the late Abu Bakr al-Baghdadi.

Jasim has a $5 million bounty on his head from the U.S. State Department’s Rewards for Justice program, which describes him as having been “instrumental in managing finances for IS terrorist operations.”

“While serving as IS deputy in southern Mosul in 2014, Jasim reportedly served as the equivalent of IS’s finance minister, supervising the group’s revenue-generating operations from illicit sales of oil, gas, antiquities, and minerals,” the website says.

Iraqi intelligence officials told The Associated Press that Jasim was detained in an identified foreign country and transported to Iraq few days ago. They spoke on condition of anonymity because they were not authorized to speak of the operation on the record.

Jassem worked with al-Qaida in Iraq leader Abu Musab al-Zarqawi, a Jordanian militant who was killed in a U.S. airstrike in Iraq in 2006. He assumed various security positions in Iraq, and moved to Syria in 2015, after the Islamic State group, an al-Qaida offshoot, declared its caliphate in 2014 and became the deputy of Abu Bakr al-Baghdadi, the extremist group’s leader.

Free America Network Articles

Leave a Reply

Next Post

Merck asks FDA to authorize antiviral Covid pill for emergency use

The Merck logo at the Merck campus in Rahway, New Jersey. Brendan McDermid | Reuters Merck said Monday it asked the Food and Drug Administration to authorize emergency use of its experimental antiviral pill to treat mild-to-moderate Covid-19 in adults. The U.S. drugmaker’s request came after phase three clinical trial […]

You May Like